Alamar Biosciences Announces the Launch of the NULISAseq Mouse Panel 120

Alamar Biosciences Announces the Launch of the NULISAseq Mouse Panel 120

Providing the largest and most comprehensive, high sensitivity, protein biomarker analysis to advance pre-clinical research

Latest News Alamar Biosciences Announces the Launch of the NULISAseq Mouse Panel 120 - Businessfortnight

Providing the largest and most comprehensive, high sensitivity, protein biomarker analysis to advance pre-clinical research FREMONT, Calif., March 24, 2025 /PRNewswire/ — Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce the launch of the NULISAseq Mouse Panel 120, an innovative biomarker profiling solution that provides the most comprehensive coverage of protein targets…

Providing the Largest, Most Comprehensive and Highly Sensitive Protein Biomarker Analysis to Advance Preclinical Research FREMONT, Calif., March 24, 2025 /PRNewswire/ — Alamar Biosciences, a company driving precision proteomics research for the earliest disease detection, is proud to announce the launch of the NULISAseq Mouse Panel 120. This is an innovative biomarker analysis solution that provides the most comprehensive protein target coverage…